Complexity of immunobiology of tumor necrosis factor and novel anti-TNF therapy
Tumor Necrosis Factor (TNF) was discovered almost 50 years ago as “serum factor” detected in mice following infections or administration of bacterial lipopolysaccharide (LPS), with a remarkable anti-tumor effect. Molecular cloning showed that this activity is mediated by a small protein (17 kDa), wh...
Saved in:
| Main Author: | S. А. Nedospasov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2023-06-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/2860 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current advances in bispecific T cell–engaging therapies
by: Emmanuel Owusu Ansah, et al.
Published: (2025-04-01) -
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release
by: John S. Schardt, et al.
Published: (2024-12-01) -
Cytokines, reverse genetics and anti-cytokine therapy
by: M. S. Drutskaya, et al.
Published: (2019-05-01) -
There exists only one tumor necrosis factor
by: S. A. Nedospasov
Published: (2021-01-01) -
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
by: Amelia C. McCue, et al.
Published: (2024-12-01)